Premier Proteins Profile
Key Indicators
- Authorised Capital ₹ 11.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 9.93 Cr
as on 17-12-2024
- Company Age 38 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.30 Cr
as on 17-12-2024
- Satisfied Charges ₹ 13.78 Cr
as on 17-12-2024
- Revenue -51.91%
(FY 2023)
- Profit -180.96%
(FY 2023)
- Ebitda 6.22%
(FY 2023)
- Net Worth -13.17%
(FY 2023)
- Total Assets -40.28%
(FY 2023)
About Premier Proteins
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 11.00 Cr and a paid-up capital of Rs 9.93 Cr.
The company currently has active open charges totaling ₹19.30 Cr. The company has closed loans amounting to ₹13.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Agrawal, Uttam Bubna, and Ramesh Sharma serve as directors at the Company.
- CIN/LLPIN
U15141MP1986PLC003345
- Company No.
003345
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Mar 1986
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Dewas, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Premier Proteins?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajesh Agrawal | Managing Director | 27-Apr-1987 | Current |
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Uttam Bubna | Director | 17-Apr-2010 | Current |
Ramesh Sharma | Director | 27-Nov-2019 | Current |
Financial Performance and Corporate Structure Insights of Premier Proteins.
Premier Proteins Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 51.91% decrease. The company also saw a substantial fall in profitability, with a 180.96% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Premier Proteins?
In 2023, Premier Proteins had a promoter holding of 32.83% and a public holding of 67.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Cargill India Private Limited Creation Date: 23 Sep 2011 | ₹6.25 Cr | Open |
State Bank Of India Creation Date: 31 Mar 1989 | ₹2.50 M | Open |
State Bank Of India Creation Date: 31 Mar 1989 | ₹6.07 Cr | Open |
How Many Employees Work at Premier Proteins?
Premier Proteins has a workforce of 27 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Premier Proteins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Premier Proteins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.